title: [The management of ulcerative colitis in remission stage and the strategies for colorectal cancer surveillance in ulcerative colitis].
authors.affiliation: Department of Gastroenterology, Tohoku University Hospital. setakahashi-gi@umin.org
authors.forename: Seiichi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Kinouchi
authors.forename: Katsuya
authors.initials: K
authors.lastname: Endo
authors.forename: Hisashi
authors.initials: H
authors.lastname: Shiga
authors.forename: Tooru
authors.initials: T
authors.lastname: Shimosegawa
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000517:prevention & control*; D006801:Humans; D019936:Probiotics / Q000627:therapeutic use; D012074:Remission Induction / Q000379:methods; D012459:Salicylates / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D053778:Thiazolidines / Q000627:therapeutic use
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D012459:Salicylates; D053778:Thiazolidines; C003438:thiazolidine-4-carboxylic acid; D000068879:Adalimumab; D016559:Tacrolimus